Loading...

Alemtuzumab for Multiple Sclerosis

Alemtuzumab is a humanised anti-CD52 monoclonal antibody approved for use in active, relapsing multiple sclerosis (MS). Administration results in a rapid depletion of circulating lymphocytes with a subsequent beneficial immune reconstitution. Early open-label experience and recent clinical trials ha...

Full description

Saved in:
Bibliographic Details
Published in:Curr Neurol Neurosci Rep
Main Authors: Willis, Mark D., Robertson, Neil P.
Format: Artigo
Language:Inglês
Published: Springer US 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4971037/
https://ncbi.nlm.nih.gov/pubmed/27485945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11910-016-0685-y
Tags: Add Tag
No Tags, Be the first to tag this record!